[May 17, 2016]

Acinetobacter Infections - Pipeline Review, H1 2016 - Review of 25 Companies & Drug Profiles - Research and Markets

Research and Markets has announced the addition of the "Acinetobacter Infections - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Acinetobacter Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acinetobacter Infections and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Acinetobacter Infections Overview
3. Therapeuics Development
4. Pipeline Products for Acinetobacter Infections - Overview
5. Pipeline Products for Acinetobacter Infections - Comparative Analysis
6. Acinetobacter Infections - Therapeutics under Development by Companies
7. Acinetobacter Infections - Therapeutics under Investigation by Universities/Institutes
8. Acinetobacter Infections Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Acinetobacter Infections - Products under Development by Companies
13. Acinetobacter Infections - Products under Investigation by Universities/Institutes
14. Acinetobacter Infections - Companies Involved in Therapeutics Development

• Achaogen Inc.
• Adenium Biotech ApS
• AmpliPhi Biosciences Corporation
• Aridis Pharmaceuticals LLC
• AstraZeneca Plc
• AvidBiotics Corp.
• Cellceutix Corporation
• Emergent BioSolutions Inc.
• Evaxion Biotech ApS
• F. Hoffmann-La Roche Ltd.
• FOB Synthesis, Inc.
• LegoChem Biosciences, Inc
• Melinta Therapeutics, Inc
• MicuRx Pharmaceuticals, Inc.
• Nosopharm SAS (News - Alert)
• Omnia Molecular Ltd.
• Pfizer Inc.
• Phylogica Limited
• Sarepta Therapeutics, Inc.
• Sealife PHARMA GMBH
• Shionogi & Co., Ltd.
• Techulon, Inc.
• Tetraphase Pharmaceuticals Inc.
• Varinel, Inc.
• Vaxdyn, S.L.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160517006180/en/

[ Back To TMCnet.com's Homepage ]